1321 pages found
Medicare Advantage Open Enrollment begins Jan. 1
While the Medicare open enrollment period is over, the Medicare Advantage Open Enrollment Period (MA OEP) is open January 1–March 31, 2025. During this time, current Medicare Advantage enrollees can switch to a different Medicare Advantage plan, return to original Medicare, and/or add a Medicare Part D prescription drug plan.
Update: All Clear on Lockdown of Blessing Hospital at 11th Street
The lockdown of Blessing Hospital’s 11th Street campus and the Blessing Health Center has been lifted. The threat has been resolved and those entering the buildings will no longer be screened.
Progressive Care Unit RN Receives International DAISY Award
Kaylan Drebes, RN, BSN, Progressive Care Unit, Blessing Hospital, became the 29th Blessing nurse to receive the international DAISY Award.
Medicare Advantage informational open house in Hannibal
Northeast Missouri residents who receive their care from Blessing Health are invited to an open-house-style information session on Medicare Advantage plan changes at Blessing on Wednesday, October 30, anytime between the hours of Noon and 2 pm.
Blessing Physician Services to expand its drive-through healthcare services
Blessing Physician Services (BPS) will bring new life to a vacant building on the grounds of the Quincy Mall and increase the convenience of receiving healthcare at the same time. A drive-through healthcare service called Blessing Express Clinic is scheduled to open on January 4 in the building that housed Sears automotive services.
Blessing hosts first Medicare Advantage open house on Oct. 15
The first of eight open-house-style informational sessions on Medicare Advantage plan changes at Blessing Health System takes place Tuesday, October 15, at the Blessing Resource Center, 420 N. 34th Street, Quincy
Blessing Health System expands access to COVID-19 outpatient treatment
A new process at Blessing Health System will facilitate access to the COVID-19 outpatient drug Bamlanivimab. As supplies last, it will be made available to confirmed positive COVID patients who meet the drug’s required criteria.